Biotech, Nektar Therapeutics Can't Handle Mondays

Biotech, Nektar Therapeutics Can't Handle Mondays


Nektar Therapeutics went on a rollercoaster ride last week, and is down again today, following a downgrade, along with much of the rest of biotech. Two Mondays in a row of dipping into the red.



from Biotech News